Rhombus Pharma Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 9.35 M
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 27.95 Cr
- Satisfied Charges ₹ 9.45 Cr
- Revenue Growth -9.97%
- Profit Growth 3.80%
- Ebitda -14.54%
- Net Worth 62.47%
- Total Assets 50.30%
About Rhombus Pharma
Rhombus Pharma Pvt Ltd (RPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 December 1995 and has a history of 29 years and two months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 9.35 M.
The company currently has active open charges totaling ₹27.95 Cr. The company has closed loans amounting to ₹9.45 Cr, as per Ministry of Corporate Affairs (MCA) records.
Jayulkumar Dhirajlal, Vasantiben Vaghani, and Dhirajlal Vaghani serve as directors at the Company.
Company Details
-
Location
Gandhi Nagar, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U15400GJ1995PTC028287
-
Company No.
028287
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
04 Dec 1995
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
What products or services does Rhombus Pharma Pvt Ltd offer?
Rhombus Pharma Pvt Ltd offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Pharma Franchise, PCD Pharma Franchise, Pharmaceutical Medicine, Metformin Tablets, Vitamin & Multivitamin Injections, Methylcobalamin Injection, Antibacterial Drugs, Cefoperazone Sulbactam Injection.
Who are the key members and board of directors at Rhombus Pharma?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dhirajlal Vaghani
|
Managing Director | 24-Jun-1996 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Jayulkumar Dhirajlal
|
Director | 03-Jul-2010 | Current |
|
Vasantiben Vaghani
|
Director | 24-Jun-1996 | Current |
Financial Performance of Rhombus Pharma.
Rhombus Pharma Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 9.97% decrease. The company also saw a slight improvement in profitability, with a 3.8% increase in profit. The company's net worth Soared by an impressive increase of 62.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rhombus Pharma?
In 2023, Rhombus Pharma had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹27.95 Cr
₹9.45 Cr
Charges Breakdown by Lending Institutions
- Sidbi : 27.95 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Jul 2024 | Sidbi | ₹9.53 M | Open |
| 22 Mar 2024 | Sidbi | ₹2.00 Cr | Open |
| 13 Feb 2023 | Sidbi | ₹20.00 Cr | Open |
| 23 Aug 2022 | Sidbi | ₹5.00 Cr | Open |
| 13 Aug 2021 | Sidbi | ₹2.00 Cr | Satisfied |
How Many Employees Work at Rhombus Pharma?
Rhombus Pharma has a workforce of 41 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rhombus Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rhombus Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
